Patricia A. Spears

15.5k total citations · 6 hit papers
81 papers, 10.0k citations indexed

About

Patricia A. Spears is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Patricia A. Spears has authored 81 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 19 papers in Cancer Research and 14 papers in Molecular Biology. Recurrent topics in Patricia A. Spears's work include Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (14 papers) and RNA and protein synthesis mechanisms (8 papers). Patricia A. Spears is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (14 papers) and RNA and protein synthesis mechanisms (8 papers). Patricia A. Spears collaborates with scholars based in United States, Canada and United Kingdom. Patricia A. Spears's co-authors include Kimberly H. Allison, Antonio C. Wolff, Lisa M. McShane, Mitch Dowsett, Pamela B. Mangu, Patrick L. Fitzgibbons, Michael F. Press, Wedad Hanna, Gail H. Vance and Michael Bilous and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Patricia A. Spears

78 papers receiving 9.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2013 3.1k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology profile →
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

2018 1.5k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology profile →
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2013 1.3k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Archives of Pathology & Laboratory Medicine profile →
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

2018 1.0k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Archives of Pathology & Laboratory Medicine profile →
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

2021 592 citations Larissa A. Korde, Mark R. Somerfield et al. Journal of Clinical Oncology profile →
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update

2023 251 citations Antonio C. Wolff, Mark R. Somerfield et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia A. Spears United States	29	5.9k	4.4k	2.4k	2.1k	1.8k	81	10.0k
M. Elizabeth Hammond United States	28	6.7k 1.1×	4.0k 0.9×	2.4k 1.0×	2.2k 1.1×	2.0k 1.2×	60	11.5k
Shinji Ohno Japan	51	4.5k 0.8×	3.3k 0.8×	1.4k 0.6×	2.4k 1.2×	2.3k 1.3×	370	11.1k
Rebecca Gelman United States	63	6.8k 1.1×	6.5k 1.5×	1.8k 0.7×	2.4k 1.2×	2.6k 1.5×	223	16.1k
Brian J. Czerniecki United States	51	3.8k 0.6×	2.5k 0.6×	2.3k 0.9×	1.5k 0.7×	799 0.5×	228	8.6k
Ruud H. Brakenhoff Netherlands	59	6.0k 1.0×	3.8k 0.9×	943 0.4×	6.2k 3.0×	2.4k 1.4×	242	15.7k
Kenneth K. Tanabe United States	58	4.4k 0.7×	1.7k 0.4×	1.1k 0.5×	3.2k 1.5×	2.0k 1.1×	236	11.6k
Charles L. Vogel United States	56	11.4k 1.9×	3.6k 0.8×	4.4k 1.8×	3.6k 1.7×	2.7k 1.5×	163	16.8k
Dirk Jäger Germany	48	6.8k 1.2×	2.2k 0.5×	2.1k 0.9×	2.9k 1.4×	1.9k 1.1×	220	11.8k
Stig Nordling Finland	49	2.7k 0.5×	1.5k 0.3×	984 0.4×	3.1k 1.5×	3.8k 2.2×	206	10.1k
Christine H. Chung United States	52	5.6k 1.0×	2.4k 0.5×	1.4k 0.6×	4.7k 2.2×	3.6k 2.0×	255	15.6k

Countries citing papers authored by Patricia A. Spears

Since Specialization

Citations

This map shows the geographic impact of Patricia A. Spears's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia A. Spears with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia A. Spears more than expected).

Fields of papers citing papers by Patricia A. Spears

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia A. Spears. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia A. Spears. The network helps show where Patricia A. Spears may publish in the future.

Co-authorship network of co-authors of Patricia A. Spears

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia A. Spears. A scholar is included among the top collaborators of Patricia A. Spears based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia A. Spears. Patricia A. Spears is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sella, Tal, et al.. (2024). Abstract PO4-01-11: Ovarian function suppression (OFS) use beyond five years?: Young breast cancer patient preferences. Cancer Research. 84(9_Supplement). PO4–1.

Zagami, Paola, Aranzazu Fernández-Martínez, Naim U. Rashid, et al.. (2023). Association of PIK3CA Mutation With Pathologic Complete Response and Outcome by Hormone Receptor Status and Intrinsic Subtype in Early-Stage ERBB2/HER2-Positive Breast Cancer. JAMA Network Open. 6(12). e2348814–e2348814. 4 indexed citations

Wolff, Antonio C., Mark R. Somerfield, Mitch Dowsett, et al.. (2023). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update. Journal of Clinical Oncology. 41(22). 3867–3872. 251 indexed citations breakdown →

Edwards, Teresa, Jennifer Fine, Susan Martin, et al.. (2023). Side effects and impacts of extended adjuvant endocrine therapy: A qualitative study among women with HR+/HER2- breast cancer.. Journal of Clinical Oncology. 41(16_suppl). e12509–e12509. 1 indexed citations

Fernández-Martínez, Aranzazu, Tomás Pascual, Baljit Singh, et al.. (2023). Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer. JAMA Oncology. 9(4). 490–490. 36 indexed citations

Fernández-Martínez, Aranzazu, Mattia Rediti, Gong Tang, et al.. (2022). Prognostic and predictive implications of the intrinsic subtypes and gene expression signatures in early-stage HER2+ breast cancer: A pooled analysis of CALGB 40601, NeoALTTO, and NSABP B-41 trials.. Journal of Clinical Oncology. 40(16_suppl). 509–509. 4 indexed citations

Korde, Larissa A., Mark R. Somerfield, Lisa A. Carey, et al.. (2021). Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Journal of Clinical Oncology. 39(13). 1485–1505. 592 indexed citations breakdown →

Basch, Ethan, Deborah Schrag, Jennifer Jansen, et al.. (2021). Digital symptom monitoring with patient-reported outcomes in community oncology practices: A U.S. national cluster randomized trial.. Journal of Clinical Oncology. 39(36_suppl). 349527–349527. 10 indexed citations

Stover, Angela M., Allison M. Deal, Jennifer Jansen, et al.. (2019). Development and testing of patient-reported outcome performance measures (PRO-PMs) for oncology practice.. Journal of Clinical Oncology. 37(27_suppl). 173–173. 1 indexed citations

10.

Wolff, Antonio C., M. Elizabeth Hammond, Kimberly H. Allison, et al.. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Journal of Clinical Oncology. 36(20). 2105–2122. 1545 indexed citations breakdown →

11.

Recht, Abram, Elizabeth Comen, Richard E. Fine, et al.. (2016). Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Practical Radiation Oncology. 6(6). e219–e234. 129 indexed citations

12.

Wolff, Antonio C., M. Elizabeth Hammond, David G. Hicks, et al.. (2013). Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Archives of Pathology & Laboratory Medicine. 138(2). 241–256. 1307 indexed citations breakdown →

13.

Spears, Patricia A., Louise Temple, David M. Miyamoto, Duncan J. Maskell, & Paul E. Orndorff. (2003). Unexpected Similarities betweenBordetella aviumand Other Pathogenic Bordetellae. Infection and Immunity. 71(5). 2591–2597. 26 indexed citations

14.

Hamrick, Terri S., J.R. Horton, Patricia A. Spears, et al.. (2003). Influence of Pregnancy on the Pathogenesis of Listeriosis in Mice Inoculated Intragastrically. Infection and Immunity. 71(9). 5202–5209. 21 indexed citations

15.

Spears, Patricia A.. (2002). Breast cancer prevention through the eyes of a survivor. Environmental and Molecular Mutagenesis. 39(2-3). 108–111.

16.

Spears, Patricia A., et al.. (1997). Simultaneous Strand Displacement Amplification and Fluorescence Polarization Detection ofChlamydia trachomatisDNA. Analytical Biochemistry. 247(1). 130–137. 20 indexed citations

17.

Wright, David J., et al.. (1996). Detection ofM. tuberculosisDNA using Thermophilic Strand Displacement Amplification. Molecular and Cellular Probes. 10(4). 247–256. 45 indexed citations

18.

Taylor, Ronald K., Carolyn E. Shaw, Kenneth M. Peterson, Patricia A. Spears, & John J. Mekalanos. (1988). Safe, live Vibrio cholerae vaccines?. Vaccine. 6(2). 151–154. 88 indexed citations

19.

Orndorff, Paul E., Patricia A. Spears, David B. Schauer, & Stanley Falkow. (1985). Two modes of control of pilA, the gene encoding type 1 pilin in Escherichia coli. Journal of Bacteriology. 164(1). 321–330. 86 indexed citations

20.

Bowen, Richard A., Patricia A. Spears, J. Storz, & G.E. Seidel. (1978). Mechanisms of Infertility in Genital Tract Infections Due to Chlamydia psittaci Transmitted through Contaminated Semen. The Journal of Infectious Diseases. 138(1). 95–104. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact